Filed before 2025Filed 10 February 2023
Allyx Therapeutics, Inc. raised $2.31M
Allyx Therapeutics, Inc., a biotech company based in New Haven, CT, raised $2.31M in a new equity round, according to a filing dated 10 February 2023.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 10 February 2023
- Round
- Equity round
- Amount sold
- $2.31M
- Offering size
- $2.31M
- Investors so far
- 11
- Based in
- New Haven, CT
- Website
- allyxthera.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 25% of the 1,396 tracked raises with an amount filed in 2023, and than 24% of the 142 in biotech.
Allyx Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 11 May 2026 | New filing | $26.4M | Another raise |
| 3 Mar 2026 | New filing | $3.32M | Another raise |
| 10 Feb 2023 | New filing | $2.31M | This raise |
| 2 Jun 2021 | New filing | $7.58M | Another raise |
More with WHIN on the board
- Episteme Prognostics, Inc.$5.09M
- AtlasXomics Inc.$3.9M
- IsoPlexis Corp$7.5M
- ReNetX Bio, Inc.$2.8M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.